Philip Privitera to Animals
This is a "connection" page, showing publications Philip Privitera has written about Animals.
Connection Strength
0.126
-
Autoradiographic localization of [125I-Tyr0]bradykinin binding sites in brains of Wistar-Kyoto and spontaneously hypertensive rats. Cell Mol Neurobiol. 2003 Oct; 23(4-5):805-15.
Score: 0.016
-
Brain kallikrein-kinin system abnormalities in spontaneously hypertensive rats. Hypertension. 1995 Apr; 25(4 Pt 1):524-30.
Score: 0.009
-
Rostral ventrolateral medulla as a site for the central hypertensive action of kinins. Hypertension. 1994 Jan; 23(1):52-8.
Score: 0.008
-
Cerebrospinal fluid kallikrein in spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J Hypertens. 1993 Oct; 11(10):1039-45.
Score: 0.008
-
Autoradiographic visualization and characteristics of [125I]bradykinin binding sites in guinea pig brain. Brain Res. 1992 Apr 10; 577(1):73-9.
Score: 0.007
-
Brain kallikrein-kinin system in arterial pressure regulation. Agents Actions Suppl. 1992; 38 ( Pt 3):39-46.
Score: 0.007
-
A stereoselective central hypotensive action of atenolol. J Pharmacol Exp Ther. 1989 Sep; 250(3):759-63.
Score: 0.006
-
C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol. J Pharmacol Exp Ther. 1988 Aug; 246(2):529-33.
Score: 0.006
-
Afferent vagal stimulation, vasopressin, and nitroprusside alter cerebrospinal fluid kinin. Am J Physiol. 1987 Jul; 253(1 Pt 2):R136-41.
Score: 0.005
-
Site and mechanism of the centrally mediated hypotensive action of propranolol. J Pharmacol Exp Ther. 1985 Oct; 235(1):66-70.
Score: 0.005
-
Cerebrospinal fluid kinins and cardiovascular function. Effects of cerebroventricular melittin. Hypertension. 1984 Mar-Apr; 6(2 Pt 2):I46-50.
Score: 0.004
-
Persistence of myocardial failure following removal of chronic volume overload. Am J Physiol. 1982 Dec; 243(6):H876-83.
Score: 0.004
-
Utilization of a radioimmunoassay to detect the generation of Arg-Pro-Pro-Gly-Phe, a stable endproduct of bradykinin metabolism (from cultured rat aortic smooth muscle cells exposed to bradykinin). Int Immunopharmacol. 2002 Dec; 2(13-14):1995-2003.
Score: 0.004
-
Nicotinic-like effects and tissue disposition of isopropylamine. J Pharmacol Exp Ther. 1982 Jul; 222(1):116-21.
Score: 0.004
-
Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure. Science. 1981 Aug 21; 213(4510):911-3.
Score: 0.004
-
A metabolic fragment of bradykinin, Arg-Pro-Pro-Gly-Phe, protects against the deleterious effects of lipopolysaccharide in rats. J Pharmacol Exp Ther. 2001 Jan; 296(1):71-6.
Score: 0.003
-
Effects of centrally administered propranolol on plasma renin activity, plasma norepinephrine and arterial pressure. Eur J Pharmacol. 1979 Feb 15; 54(1-2):51-60.
Score: 0.003
-
Studies of the interrelationship between plasma norepinephrine, plasma renin activity and acute myocardial infarction in dogs. Res Commun Chem Pathol Pharmacol. 1978 May; 20(2):289-302.
Score: 0.003
-
Studies on the contribution of active metabolites to the anticonvulsant effects of propranolol. Eur J Pharmacol. 1977 Mar 07; 42(1):39-46.
Score: 0.003
-
Quantitative determination of propranolol, propranolol glycol and N-desisopropylpropranolol in brain tissue by electron capture gas chromatography. J Chromatogr. 1976 Jul 21; 123(1):185-92.
Score: 0.002
-
Hypertensive effect of tissue kallikrein in rostral ventrolateral medulla is mediated by brain kinins. Brain Res. 1995 Dec 15; 704(1):103-6.
Score: 0.002
-
Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197). J Pharmacol Exp Ther. 1971 Mar; 176(3):655-61.
Score: 0.002
-
A comparison of the cardiovascular effects of biogenic amines and their precursors in newborn and adult dogs. J Pharmacol Exp Ther. 1969 Apr; 166(2):293-8.
Score: 0.001
-
Stereochemistry of tissue distribution of racemic propranolol in the dog. Chirality. 1989; 1(3):192-6.
Score: 0.001
-
Cardiovascular and myocardial metabolic effects of infusions of phenylephrine. J Pharmacol Exp Ther. 1967 May; 156(2):325-30.
Score: 0.001
-
Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response. J Pharmacol Exp Ther. 1983 Aug; 226(2):324-9.
Score: 0.001
-
Furosemide increases urine 6-keto-prostaglandin F1 alpha. Relation to natriuresis, vasodilation, and renin release. Hypertension. 1982 Sep-Oct; 4(5):634-41.
Score: 0.001
-
Cardiovascular effects of a 4'-methylthio analog of propranolol. J Pharmacol Exp Ther. 1981 Dec; 219(3):685-90.
Score: 0.001
-
Effects of perhexiline on survival time and infarct size in experimental myocardial infarction. J Pharmacol Exp Ther. 1977 Jan; 200(1):155-65.
Score: 0.001
-
The importance of stable isotope labelled drugs in clinical pharmacology: with illustrations from studies on the disposition of propranolol and nortriptyline in man. South Med J. 1974 Aug; 67(8):990-1002.
Score: 0.001
-
Cardiovascular actions of a new metabolite of propranolol: isopropylamine. J Pharmacol Exp Ther. 1974 Jun; 189(3):626-32.
Score: 0.001
-
Central nervous system effects and metabolic disposition of a glycol metabolite of propranolol. J Pharmacol Exp Ther. 1974 Jan; 188(1):86-92.
Score: 0.001
-
The psychopharmacological effects of a new metabolite of propranolol. Adv Biochem Psychopharmacol. 1973; 7:107-12.
Score: 0.000
-
Hemodynamic effects of phenoxybenzamine in anesthetized dogs. J Clin Invest. 1970 Nov; 49(11):2036-50.
Score: 0.000
-
Effects of hydrocortisone on survival in neonatal beagles given endotoxin. Proc Soc Exp Biol Med. 1968 May; 128(1):326-9.
Score: 0.000